"Helicobacter pylori" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).
| Descriptor ID |
D016480
|
| MeSH Number(s) |
B03.440.500.550 B03.660.150.280.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Helicobacter pylori".
Below are MeSH descriptors whose meaning is more specific than "Helicobacter pylori".
This graph shows the total number of publications written about "Helicobacter pylori" by people in this website by year, and whether "Helicobacter pylori" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 15 | 0 | 15 |
| 1995 | 16 | 1 | 17 |
| 1996 | 31 | 6 | 37 |
| 1997 | 31 | 1 | 32 |
| 1998 | 24 | 1 | 25 |
| 1999 | 31 | 6 | 37 |
| 2000 | 37 | 4 | 41 |
| 2001 | 21 | 7 | 28 |
| 2002 | 31 | 4 | 35 |
| 2003 | 32 | 4 | 36 |
| 2004 | 19 | 5 | 24 |
| 2005 | 26 | 5 | 31 |
| 2006 | 21 | 6 | 27 |
| 2007 | 17 | 3 | 20 |
| 2008 | 30 | 5 | 35 |
| 2009 | 31 | 5 | 36 |
| 2010 | 25 | 7 | 32 |
| 2011 | 25 | 4 | 29 |
| 2012 | 23 | 4 | 27 |
| 2013 | 25 | 4 | 29 |
| 2014 | 27 | 5 | 32 |
| 2015 | 30 | 4 | 34 |
| 2016 | 21 | 3 | 24 |
| 2017 | 26 | 6 | 32 |
| 2018 | 33 | 8 | 41 |
| 2019 | 22 | 5 | 27 |
| 2020 | 29 | 7 | 36 |
| 2021 | 24 | 2 | 26 |
| 2022 | 21 | 0 | 21 |
| 2023 | 28 | 0 | 28 |
| 2024 | 16 | 1 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Helicobacter pylori" by people in Profiles.
-
Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori-Infected Peptic Ulcer Children in Vietnam. Helicobacter. 2024 Nov-Dec; 29(6):e13149.
-
An ancient ecospecies of Helicobacter pylori. Nature. 2024 Nov; 635(8037):178-185.
-
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut. 2024 Sep 09; 73(10):1607-1617.
-
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice. Expert Rev Gastroenterol Hepatol. 2024 Aug; 18(8):457-472.
-
Synergistic effects of novel penicillin-binding protein 1A amino acid substitutions contribute to high-level amoxicillin resistance of Helicobacter pylori. mSphere. 2024 Aug 28; 9(8):e0008924.
-
Self-Correcting Method for Highly Effective Office-Based Helicobacter pylori Therapy Using Cumulative Test of Cure Data. Helicobacter. 2024 Jul-Aug; 29(4):e13112.
-
Helicobacter pylori infection does not influence the progression from gastroesophageal reflux disease to Barrett's esophagus to esophageal adenocarcinoma. Minerva Gastroenterol (Torino). 2024 Dec; 70(4):454-462.
-
Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review. Helicobacter. 2024 May-Jun; 29(3):e13106.
-
Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial). Sci Rep. 2024 04 18; 14(1):8986.
-
Proportion of cancer cases and deaths attributable to potentially modifiable risk factors in Peru. BMC Cancer. 2024 Apr 15; 24(1):477.